Protein in Feeding Strategies to Accelerate Muscle Recovery From ACL Reconstruction

Sponsor
University of Connecticut (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03492021
Collaborator
Orthopedic Associates of Hartford (Other), United States Army Research Institute of Environmental Medicine (U.S. Fed), University of California, Berkeley (Other)
20
1
2
48
0.4

Study Details

Study Description

Brief Summary

Musculoskeletal injury, particularly injuries requiring surgical repair, induce significant muscle atrophy, resulting in diminished physical function. The protein turnover-associated (diminished protein synthesis, elevated protein breakdown, negative net muscle protein balance) etiology of injury and surgical-induced atrophy are, in part, similar to those observed with muscle wasting induced by hyper-catabolic and inflammatory conditions and prolonged periods of skeletal muscle disuse (e.g., cachexia and joint immobilization). Combining dietary strategies to optimize the anabolic properties of beef as a high quality protein source that provides essential amino acids prior to surgery and throughout post-surgery rehabilitation may attenuate muscle atrophy and accelerate the restoration of muscle function. This project will examine the efficacy of habitual consumption of a beef-based higher protein meal pattern and post-physical rehabilitation beef protein supplementation throughout post-surgical rehabilitation intervention on skeletal muscle function in response to anterior cruciate ligament (ACL) repair in healthy, physically active adults.

Stable isotope methodologies, proteomic analysis of muscle protein synthesis, and molecular assessments of skeletal muscle atrophy and remodeling will be assessed to evaluate the effects of increased protein intake, including consumption of a high quality beef-based protein supplement following patient physical therapy sessions on:

  1. Skeletal muscle protein fractional synthetic rates during and in recovery from surgery;

  2. Inflammatory, proteolytic, and anabolic intramuscular signaling during surgery and their association with skeletal muscle protein synthesis and muscle function;

  3. Muscle size and functional recovery;

  4. Duration to return to routine exercise, sport, or physical activity.

Condition or Disease Intervention/Treatment Phase
  • Other: Diet Intervention_AP-CPT
  • Other: Diet Intervention_PP-PPT
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Role of Beef in Optimal Protein and Feeding Strategies to Accelerate Muscle Mass and Functional Recovery From Anterior Cruciate Ligament (ACL) Repair
Actual Study Start Date :
Feb 1, 2018
Actual Primary Completion Date :
Jul 31, 2021
Anticipated Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adequate Protein_Carbohydrate Post Therapy

Diet Intervention - Adequate Protein (1.0 g/kg/d) - Carbohydrate Post Therapy [AP-CPT]

Other: Diet Intervention_AP-CPT
Adequate Protein_Carbohydrate Post Therapy (AP-CPT) where protein intake will be 1 g/kg/d for the duration of the study .

Experimental: Optimal Protein_Protein Post Therapy

Diet Intervention - Optimal Protein (2.0 g/kg/d) - Protein Post Therapy [OP-PPT]

Other: Diet Intervention_PP-PPT
Optimal Protein_Protein Post Therapy (OP-PPT) with protein intake set at 2.0 g/kg/day for the duration of the study

Outcome Measures

Primary Outcome Measures

  1. Skeletal muscle protein fractional synthetic rates [Following 16 weeks of physical rehabilitation post surgery for subjects in both diet intervention groups.]

    Using stable isotope techniques skeletal muscle protein fractional synthetic rates will be determined

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 to 50 years of age

  • identified as appropriate for study recruitment by their respective orthopedic surgeon

  • undergoing their first anterior cruciate ligament (ACL) repair

  • undergo ACL reconstruction under general anesthesia

  • body mass indexes (BMIs) within normal to overweight ranges

Exclusion Criteria:
  • reporting metabolic or cardiovascular abnormalities, food allergies, gastrointestinal disorders (i.e. lactose intolerance)

  • use of nutritional/herbal/sports supplements including anabolic steroids, and tobacco products will be excluded from the study

  • BMIs above 29.9

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orthopedic Associates of Hartford Hartford Connecticut United States 06106

Sponsors and Collaborators

  • University of Connecticut
  • Orthopedic Associates of Hartford
  • United States Army Research Institute of Environmental Medicine
  • University of California, Berkeley

Investigators

  • Principal Investigator: Nancy R Rodriguez, PhD, University of Connecticut-Storrs

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nancy Rodriguez, Professor, University of Connecticut
ClinicalTrials.gov Identifier:
NCT03492021
Other Study ID Numbers:
  • HHC-E-HHC-2016-0126
  • KFS63669550
First Posted:
Apr 9, 2018
Last Update Posted:
Dec 20, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nancy Rodriguez, Professor, University of Connecticut

Study Results

No Results Posted as of Dec 20, 2021